Proteomics-based Development of Biomarkers in Cardiovascular Disease (2006)

Cardiovascular disease remains a paramount focus of basic science and clinical investigation throughout the developed world, although the demographics have changed considerably in the later half of the 20th century. Atherosclerotic cardiovascular disease, especially ischemic heart disease, has emerged as the major concern, while rheumatic fever and its cardiac sequelae have been superseded by congenital heart disease. Understanding these disease states and their perturbations requires clarification of mechanistic changes in organ phenotype over time, the influence of genetic variations, and the effects of pharmacologic, surgical, and interventional treatment. These requirements have been addressed, in part, by genetic, biochemical, and system approaches. It is clear, however, that knowledge of the DNA sequence, although essential, is not sufficient. A more meaningful understanding of gene expression can be achieved through characterization of the products of that expression, the proteins that are the essential biological determinants of disease phenotype. The ultimate phenotype of cell, organ, and organism is reflected in the instantaneous proteomic profile; similarly changes in human states of health are the result of changes in the proteomes of individual patients over time in response to endogenous and/or external stimuli. The advent of novel proteomic approaches to investigate the complexity of human illness promises to shed new light on the pathogenesis of a broad range of cardiovascular diseases. These inferences are multifaceted and include the commonly recognized role of proteomics in characterizing biomarkers and biosignatures for the prognosis and diagnosis of disease, the capability of these technologies of revealing information regarding functional subproteomes of organelles and networks in the heart and vasculature, and the importance of proteomics in defining changes in these functional subproteomes to guide future therapy. The central focus of this review is to discuss the importance of proteomics as a non-biased tool for protein discovery. We explore the role of proteomics for hypothesis-driven research into cellular organelle status, and we discuss how this approach facilitates an understanding of the function of the cell in normal and diseased states. Lastly we present a review of proteomics as a tool for biomarker development and lay out a vision for how this technology promises to facilitate distinct biomarker development. Signal transduction pathways are an experimental challenge in the study of complex cell/organ systems. The proteins and the interactions between molecules and post-translational modifications must be studied to understand how inputs into a cell are processed to modulate the phenotype of an organ. Pharmacologic and genetic interventions provide mechanisms by which single molecules can be targeted, thus creating experimental lesions in a signaling pathway that yield insights into the function of its components. Recent investigations in which these types of perturbations have been melded with proteomic analyses of the networks and pathways have afforded novel descriptions of cardiac cell signaling not possible previously. Importantly the biomedical profession has available an invaluable resource of web-based two-dimensional electrophoretic maps annotated for healthy and diseased cardiac tissues (such as failing myocardium) in a number of extensively characterized species. These resources have recently been highlighted in a comprehensive review by McGregor and Dunn (1McGregor E. Dunn M.J. Proteomics of the heart: unraveling disease.Circ. Res. 2006; 98: 309-321Crossref PubMed Scopus (119) Google Scholar). The failing myocardium characteristically displays impaired sarcoplasmic reticulum calcium cycling. It is well established that phospholamban activity is inversely related to the capability of the SR 1The abbreviations used are: SR, sarcoplasmic reticulum; 2D, two-dimensional; PTM, post-translational modification; HSP, heat shock protein; PKC, protein kinase C; EC, endothelial cell; HUVEC, human umbilical vein endothelial cell; 2-DE, two-dimensional gel electrophoresis; SMC, smooth muscle cell; EPC, endothelial progenitor cell; CRP, C-reactive protein. to cycle calcium, and thus an understanding of how this protein modulates the SR subproteome is of critical importance in developing new therapeutic strategies that aim at modulating the performance of the failing heart at the molecular level. Chu et al. (2Chu G. Kerr J.P. Mitton B. Egnaczyk G.F. Vazquez J.A. Shen M. Kilby G.W. Stevenson T.I. Maggio J.E. Vockley J. Rapundalo S.T. Kranias E.G. Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling.FASEB J. 2004; 18: 1725-1727Crossref PubMed Scopus (24) Google Scholar) used classical 2D electrophoresis and mass spectrometry to examine protein changes in hearts from phospholamban knock-out mice as with approach in proteins and in of These in of proteins by of phospholamban and are related to enhanced cardiac performance in the understanding of how this protein modulates the SR subproteome is of critical importance in therapeutic strategies that modulate performance of the failing heart at the molecular level. of genetic of individual molecules to proteomic signaling pathways et al. G. J.E. analysis of a mouse with J. PubMed Scopus Google Scholar) the proteomic changes with in the their analyses on the and these to changed proteins by 2D in and in the of development of the phenotype the These analyses not changes in in the insights not have been possible with the genetic perturbations in Proteomics to these signaling investigations have the proteomic of cardiac function and used to an in mass in and changes in proteins by 2D electrophoresis and mass spectrometry M.J. M. Proteomic changes in the in with the of PubMed Scopus Google Scholar). the study changes in heat shock and analyses with that these molecules in the of the and of heat shock proteins for signaling in the heart M.J. M. Proteomic changes in the in with the of PubMed Scopus Google M. M. Proteomic analysis of cardiac heat shock protein expression in heart 2006; PubMed Scopus Google of on the cardiac modifications to and heart shock 2006; PubMed Scopus Google heat shock a new in PubMed Scopus Google is not that proteomic distinct of cardiac signaling in heat shock protein expression and and in a of heart in M. M. Proteomic analysis of cardiac heat shock protein expression in heart 2006; PubMed Scopus Google Scholar) and in in response to in of on the cardiac modifications to and heart shock 2006; PubMed Scopus Google Scholar). Proteomic can as of and analyses to the signaling proteomic analyses of the protein kinase signaling subproteome of the molecular of this the in which these proteins with and their and functional on these proteomic in novel for in modulating endothelial and through signaling J. G. proteomic analysis of a signaling in cardiac J. PubMed Scopus Google Scholar) and in modulating in cardiac G.W. J. kinase with and the in cardiac Res. PubMed Scopus Google Scholar). These insights by a proteomic of the signaling pathways in the phenotype. Proteomic investigations related to signaling in the myocardium have been used to in signaling mechanisms in cardiac G.W. J. kinase with and the in cardiac Res. PubMed Scopus Google two-dimensional a tool for functional proteomics of and signaling PubMed Scopus Google B. J. Proteomic analysis of and and by from and mouse heart 2006; PubMed Scopus Google G. Proteomics of in myocardium to proteins of essential functional PubMed Scopus Google proteomic in and pathways in 2004; PubMed Scopus Google Scholar). Proteomic analysis of hearts cell and gel and protein changes 2D electrophoresis in with response as well as in G. Proteomics of in myocardium to proteins of essential functional PubMed Scopus Google Scholar). These the of proteomics for changes in signaling as which not be by signaling in function in the heart proteomic in and pathways in 2004; PubMed Scopus Google Scholar) in which to the of these to the with to that these changes in signaling as of disease and mechanisms of proteomic in and pathways in 2004; PubMed Scopus Google Scholar). analyses of B. J. Proteomic analysis of and and by from and mouse heart 2006; PubMed Scopus Google proteomic analyses used to the molecular in signaling at these critical of function and cell and proteomic the subproteome of molecules with these of the the for future functional analyses of how signaling pathways modulate function and these how proteomics the of cellular networks in the heart while in a non-biased the mechanisms of by post-translational insights into cellular pathway and function not have been possible with genetic and in a functional proteomic approach facilitates an understanding of signaling pathways in the with of proteomic proteomics is in its a proteomics to the have been and the of of is A major to the proteomic analysis of is their cellular to proteomic to human have been by the of proteins and the biological in human lesions J. J. E. of on human protein gel electrophoretic PubMed Scopus Google E. of proteins in and PubMed Scopus (24) Google J. E. protein of PubMed Scopus Google J. J. J. Proteomic analysis of human to PubMed Scopus Google G. M. Proteomic approach to light as a with in PubMed Scopus Google Scholar). strategies have been to this the from human E. M. Dunn M.J. and vein smooth muscle proteins are by a proteomic 2004; PubMed Scopus Google Scholar) of in to proteins in the J. J. J. Proteomic analysis of human to PubMed Scopus Google Scholar). with the of and the mouse the in cardiovascular research J.A. of mice a gene by gene in PubMed Scopus Google and in mice by in PubMed Scopus Google J.A. and lesions in mice PubMed Scopus Google the to protein changes of well and in with genetic proteomic by biological we 2D gel protein of to their in with and M. Proteomic and analyses of from mice in and PubMed Scopus Google a of the which for of the a in of disease. The of 2D proteins can be proteomic of tissues with cell by their cellular proteomic disease to is the of present in must be that are to to in cell with and protein expression E. M. Dunn M.J. and of human vein smooth muscle proteins by two-dimensional gel PubMed Scopus Google a protein modulating effects of PubMed Scopus Google Scholar). has not been on endothelial from and umbilical vein endothelial from are the in annotated maps J. M. B. Proteomic study of human umbilical vein endothelial in PubMed Scopus Google G. of gene expression by in human umbilical vein endothelial a and proteomic 2004; PubMed Scopus Google Scholar) have been has been on endothelial Proteomic analysis of the proteins by human endothelial PubMed Scopus Google M. proteins in human endothelial by two-dimensional gel electrophoresis and mass 2004; PubMed Scopus Google Scholar) and in the human endothelial cell G. in the of human endothelial PubMed Scopus Google Proteomics analysis of human endothelial cell to 2004; PubMed Scopus Google Scholar) by of with the human cell cell human established by PubMed Scopus Google Scholar). The smooth muscle cell is used the to include cell that a the endothelial smooth muscle and smooth muscle PubMed Scopus Google Scholar). to in of the from the and the from the the the the and the from the a has been muscle from of the and distinct Res. PubMed Scopus Google distinct smooth muscle cell in the and developing in Res. PubMed Scopus Google Scholar). can and and pathways the of in human smooth muscle PubMed Scopus Google muscle cell of gene expression in smooth muscle in and in 18: PubMed Scopus Google G. of in and PubMed Scopus Google and their distinct of expression in human PubMed Scopus Google can from the and to can to smooth muscle in Res. PubMed Scopus Google Scholar). this the proteomics be in a understanding of cell and in a molecular on protein expression of cell a we have recently the of progenitor the from to and their with M. Proteomic and analyses of from mice in and PubMed Scopus Google M. E. Proteomic of progenitor PubMed Scopus Google Scholar). A of maps is available E. M. Dunn M.J. and vein smooth muscle proteins are by a proteomic 2004; PubMed Scopus Google B. The and of human smooth muscle PubMed Scopus Google Scholar). of in proteomics on the of are are the of smooth and that in a of congenital heart from the to of in congenital heart light and PubMed Scopus Google Scholar) and in the of the of patients with congenital heart disease M. in with congenital heart J. 2004; PubMed Scopus Google Scholar). to the is a of of of complex and and calcium which are to of the is a complex with in its The disease is to from an between and the genetic of is the that the The pathogenesis of J. PubMed Scopus Google J. PubMed Scopus Google J.A. A role for in J. PubMed Scopus Google and has a role the of an of and to a of in a between and an and smooth muscle and and of Cardiovascular and to endothelial with of and of of in the and of that the of and a of endothelial in cardiovascular the role of Res. PubMed Scopus Google Scholar). The the an of the and of lesions in of and Google A of and lesions of A from the on of the on PubMed Scopus Google Scholar). lesions of with cell by the of of the an the endothelial and and and the PubMed Scopus Google Scholar). The of that endothelial to of and that with and is that endothelial progenitor to by endothelial and that lesions are not from the from progenitor B. M. M. M. muscle in lesions are from not progenitor PubMed Scopus Google and in lesions of are by progenitor PubMed Scopus Google M. B. M. and of smooth muscle in vein Res. PubMed Google progenitor characterization and role in Res. 2004; PubMed Scopus Google Scholar) remains to M. M. into that in the pathogenesis of PubMed Scopus Google M. of to Res. PubMed Scopus Google Scholar). Importantly the number of with endothelial function G. J.P. endothelial progenitor and cardiovascular J. PubMed Scopus Google is in with and the of future cardiovascular disease M. G. endothelial progenitor and cardiovascular J. PubMed Scopus Google Scholar). the of to be a biomarker of cardiovascular of is that the of between the development of the and in and as in PubMed Scopus Google Scholar). technologies a more comprehensive understanding of the complex disease The between and the and of congenital heart disease has recently to light congenital heart disease and J. PubMed Scopus Google Scholar). is of the in the and is for heart heart and disease. and research and the in understanding the genetic of its remains of have been characterized in these for more a of and new from human genetic PubMed Scopus Google mechanisms of human PubMed Scopus Google Scholar). and have of the with with of these of and that to M. of human 2006; PubMed Scopus Google Scholar). Proteomic approaches provide to gene products to function by the of proteins These can be used to the of The pathogenesis of with of the The of B. Scholar) to proteomic of study that a gene of as for a disease is an study in which a single a of is with a of the disease. It is the in these that the gene the gene for the disease Proteomic in which the proteins are as an can to and the that a gene is of human PubMed Scopus Google Scholar). in which analysis has genetic research strategies is from in which are developed and from in which from has been into a with the genetic M. for 2004; PubMed Scopus Google Scholar). These in phenotype of and endothelial proteins from and of the by mass spectrometry with M. and with an mass and the analysis PubMed Scopus Google Scholar). The of a resource for the study in related of complex as thus the complexity of the proteomic Proteomic analysis of in can to understanding of cardiovascular diseases. A of can be in which proteins to are at the molecular in cell as for protein and in cell pathways to the can be M. M.J. J. J.P. B. and proteomic analyses of gene expression in 2004; PubMed Scopus Google Scholar). proteomic approach has the to of signaling and to provide new insights into the molecular mechanisms human a result of proteomic of critical pathways be to new for development of novel in proteomic technologies and analyses more characterization of the cellular with the of genetic and a of insights not possible with DNA in understanding of protein modifications and interactions new and therapeutic approaches to the of cardiovascular disease. to changes in protein expression and protein investigations in signaling have highlighted the importance of on the function of cell a study by and J. and post-translational of the of 2006; PubMed Scopus Google the importance of as a the the and and a novel that can be used in to subproteomes by to have changes in of endothelial cell proteins in the of and and the role of these modifications the approaches how analysis of to proteomics proteomics on can yield functional information the of the heart and not include of not of the of cardiovascular disease are characterized by of that provide to investigate the of of proteomics to congenital heart disease and the effects of congenital heart disease congenital heart disease and J. PubMed Scopus Google genetic of congenital heart disease is by cardiac congenital heart disease and J. PubMed Scopus Google in to experimental to in of and in in B. in congenital in in B. essential with of the The of B. the of by in the heart the of in response to in the heart in B. of smooth and in the of in congenital heart disease of in congenital heart light and PubMed Scopus Google and the of patients to by in B. Scholar). The cell types in the cardiovascular system include cardiac smooth muscle and endothelial the number of proteins by the cardiovascular is the complexity of the cellular proteomes is recognized and is the of proteomic of this complexity by the into more by on organelle proteomes an more an for and functional of the this organelle proteomic the proteins with distinct which are with the biological in which thus the functional of proteomic the essential cardiovascular cellular and have proteomics in the cardiovascular et al. E. B. of the human heart PubMed Scopus Google et al. J. M. E. M. M. analysis of protein and gene in mouse PubMed Scopus Google et al. M. organelle by protein 2006; PubMed Scopus Google et al. G. M. proteomic of from and 2006; PubMed Scopus Google et al. B. M. J. B. of organ and organelle protein expression in proteomic and 2006; Scopus Google et al. E. J. J.E. J.E. of the endothelial cell in and in cell 2004; PubMed Scopus Google et al. G. J.E. analysis of a mouse with J. PubMed Scopus Google et al. E. J. G.W. the cardiac Res. 2006; PubMed Scopus Google et al. G.W. B. of cardiac Res. 2006; PubMed Scopus Google A number of investigations have enhanced understanding of the of in et al. E. B. of the human heart PubMed Scopus Google Scholar) have characterized the human heart and a of distinct protein the of proteins by as the et al. J. M. E. M. M. analysis of protein and gene in mouse PubMed Scopus Google Scholar) a of proteins in mouse heart the investigation afforded the on cardiac organelle information regarding the and the of the used for these by the G. M. proteomic of from and 2006; PubMed Scopus Google M. organelle by protein 2006; PubMed Scopus Google a more technology used in which proteins from and muscle by proteomic by protein protein is a novel to protein to proteins from organelles that proteins that to and B. M. J. B. of organ and organelle protein expression in proteomic and 2006; Scopus Google Scholar) proteomic and analysis to protein expression of organelles and in mouse and proteins by which proteins from cardiac The of proteomics for analyses by and J.E. in the Res. 98: PubMed Scopus Google Scholar). The the and of a approach in proteomic that have been mass gel electrophoresis and by and Importantly the of protein from the of protein proteins into a The to its role as the with and is of in basic molecular cell and the which are to be in and signaling that cellular These and are in of molecules and signaling as endothelial and J.E. for new PubMed Scopus Google Scholar). et al. E. J. J.E. J.E. of the endothelial cell in and in cell 2004; PubMed Scopus Google Scholar) the from endothelial from as well as a of endothelial that been from a The used a two-dimensional and mass spectrometry protein technology to proteins from these of the proteins from the from not in the analysis of the that been the capability of this approach to expression between and the importance of proteomics on on cell in of cardiovascular from the development of biosignatures and biomarkers cardiovascular functional subproteome analyses that to mechanistic insights of cardiovascular cardiovascular cardiovascular proteomic changes that be of diseased for the of prognosis and proteomic changes in cardiovascular proteomic changes related to of cardiovascular that over a of cardiac phenotype these proteomic changes can be by with for the of heart The proteomic changes be used as biosignatures to insights regarding the of a and/or to guide future therapy. of which we as has thus is and a of cardiovascular are a critical role in the development of and have been in on cell and gene is by the between and and in individual are to be for by of individual at a single time are to shed A more comprehensive approach be to understand complex biological of Res. PubMed Scopus Google Scholar). We have that the of a novel is a for in cardiovascular tissues M. Proteomic and analyses of from mice in and PubMed Scopus Google M. McGregor E. G. M. Dunn M.J. of cardiac J. 2004; PubMed Scopus Google M. B. McGregor E. M. Dunn M.J. cardiac in J. 2004; PubMed Scopus Google Scholar). The a of the protein is the the in the is to to the is and in the is and in a a more E. M. E. A for of of are in at the J. PubMed Google Scholar). are as and the of to protein their in proteomic the role of in of in mice and with a of have that of the protein by and and PubMed Scopus Google Scholar). is a of that and are in the of with in of and with of the and of which for and M. E. Proteomic of mouse smooth muscle PubMed Scopus Google Scholar). of proteins the the to mechanisms can provide to species. These with a in human J. B. activity in human and in smooth muscle Google Scholar). proteomics a to the expression of and and to these with the of proteomics can mechanistic of phenotype that are of signaling that in impaired cell/organ mechanistic clinical of the disease and its not insights into cellular these are by their to the of a disease and the individual of Cardiovascular disease in has a of clinical biomarkers that have been in for the diagnosis of has on a and the of a protein biomarker of These biomarker on the of cardiac proteins the time and of well with the of cardiac however, in tissues with and activity in the of The advent of more biomarkers of as the of kinase more of cardiac has biomarker is the for the diagnosis of cardiac in clinical in that in a new and of on the of and biomarkers of as the cardiac J.E. the of cardiac modifications of 2004; PubMed Scopus Google Scholar). are protein biomarkers especially for M.J. for a of C-reactive and as of PubMed Scopus Google Scholar) which C-reactive protein is the The importance of in is and a of and an with and of these however, not a a response to at of the novel biomarkers for cardiovascular disease is that as a in that to a in by expression on endothelial of and the clinical of Res. PubMed Scopus Google Scholar). of of a response to and capability has a complex genetic and recently to the of E. M. E. J. and J. PubMed Scopus Google Scholar). the of proteomics to and to mechanistic are a to that proteomics is in new clinical of have the of proteomics in biomarker and to in cardiovascular Cardiovascular has the of for mass and protein from mass spectrometry of proteins to not to be the molecular of these has to be a that the of and technology for in biomarker and that is for the of proteomics for biomarker are not is on a of patients for proteins as not be for the and the for clinical Importantly for a protein to a clinical biomarker is and is essential to that the new biomarkers not disease in the of in the proteomics the of biomarker and The human and PubMed Scopus Google Scholar) a major by out that proteins a range of of proteomic proteins of The human and PubMed Scopus Google Scholar). is a in the approach to biomarker discovery. for biomarkers by diseased and healthy tissues of the of the biomarkers are and not by the proteins that of the protein this to be to the biological complexity and to the for proteomics in clinical biomarker remains to be The function of the of the in is and proteomic are to this information from DNA to to protein to the role of gene in to be A study by and and of the PubMed Scopus Google Scholar) the of analysis that is between and A comprehensive study of with proteins be and to this are and of cellular proteins to and we have 2D mass and with mouse of cardiovascular disease. Importantly 2D electrophoresis to be a proteins and their post-translational of which are in and a we mice for protein kinase M. Proteomic and analysis of smooth muscle role of Res. 2004; PubMed Google Scholar). of in and and ischemic M. McGregor E. G. M. Dunn M.J. of cardiac J. 2004; PubMed Scopus Google M. B. McGregor E. M. Dunn M.J. cardiac in J. 2004; PubMed Scopus Google Scholar). with the of an reflected by of and M. B. McGregor E. M. Dunn M.J. cardiac in J. 2004; PubMed Scopus Google and in vein protein and in the cardiovascular system in in the cellular in and in as well as in M. proteomic and 2004; PubMed Scopus Google Scholar). A comprehensive analysis of proteins and provide a understanding of complex biological and to the of disease A not be a gene a protein a be used to cardiovascular and the is and the for J.P. of 2004; PubMed Scopus Google Scholar) and is used to study cardiac and in and in to information on diagnosis and to therapeutic and the in at the of of range from to a of is established and are into the mass as well as have a for mechanistic as well as clinical biomarkers and with proteomic an of future biomarker The importance of understanding the mechanisms of cardiovascular disease, and the to human and Proteomics is a critical of to this from the of organelle and cellular biomarker and phenotype include biomarker strategies and of these strategies to clinical between basic and clinical are essential in this The of proteomic analysis on available and has the in these to strategies for to the capability of proteomics to as a clinical tool The basic science challenge that we is to that the proteomic changes in are in of is on in approaches for proteomics on this and of that this information has functional to the phenotype Proteomics has emerged as an for cellular mechanisms and for these mechanisms to cardiovascular disease and